(Q40518494)

21 September 2017

1 reference

title

Inhibitors of phospholipid intracellular signaling as antiproliferative agents (English)

1 reference

21 September 2017

Powis G

1

1 reference

21 September 2017

Hill SR

series ordinal

2

1 reference

21 September 2017

Frew TJ

series ordinal

3

1 reference

21 September 2017

Sherrill KW

series ordinal

4

1 reference

21 September 2017

1 March 1995

1 reference

Medicinal Research Reviews

21 September 2017

18

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 September 2017

15

1 reference

21 September 2017

2

1 reference

21 September 2017

121-138

1 reference

Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs by a mechanism dependent on external Ca2+.

21 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Phorbol ester and bryostatin differentially regulate the hydrolysis of phosphatidylethanolamine in Ha-ras- and raf-oncogene-transformed NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Inhibition of neural phospholipase D activity by aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Selective inhibition by 4-hydroxynonenal of sphingosine-stimulated phospholipase D in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

Inhibition of phosphatidylinositol 4-phosphate kinase by heparin. A possible mechanism for the antiproliferative effects of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150204

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/IJC.2910430519

Screening of phosphatidylinositol kinase inhibitors from Streptomyces

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.823

K-582, a new peptide antibiotic. I

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.33.533

Identifiers

DOI

10.1002/MED.2610150204

1 reference

21 September 2017

1 reference